Manufacturer copay assistance · Spevigo (J1747) · Boehringer Ingelheim
$0/dose · Maximum benefit Maximum not publicly disclosed · Covers Spevigo drug cost only — does not cover infusion administration or office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Yes — BI Solutions Plus Co-pay Assistance from Boehringer Ingelheim. Patient pays $0 per infusion. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Patient pays $0 per infusion Maximum benefit: Maximum not publicly disclosed. Covers Spevigo drug cost only — does not cover infusion administration or office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.